Similar articles

• Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.

  de Witte T, Preijers F, Schattenberg A. de Witte T, et al. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:103-5. Bone Marrow Transplant. 1990. PMID: 2202463 Review. No abstract available.
• Alloimmune effects of bone marrow transplantation for leukaemia on the leukaemic diseases.

  Marmont AM. Marmont AM. Bone Marrow Transplant. 1991;7 Suppl 2:2-3. Bone Marrow Transplant. 1991. PMID: 1878696 No abstract available.
• Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.

  Champlin R. Champlin R. Semin Hematol. 1992 Jul;29(3 Suppl 2):46-52. Semin Hematol. 1992. PMID: 1509294 Review. No abstract available.
• Bone marrow transplantation and graft-versus-host disease.

  Powles RL. Powles RL. Curr Opin Immunol. 1989-1990;2(6):870-5. Curr Opin Immunol. 1989. PMID: 2486567 Review. No abstract available.
• A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.

  Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B. Nestvold JM, et al. Transplantation. 2008 Jan 15;85(1):102-11. doi: 10.1097/01.tp.0000296856.53493.1f. Transplantation. 2008. PMID: 18192919